001     202096
005     20210129220030.0
024 7 _ |a 10.1080/07391102.2012.10507418
|2 doi
024 7 _ |a pmid:22292948
|2 pmid
024 7 _ |a 0008-7114
|2 ISSN
024 7 _ |a 1538-0254
|2 ISSN
024 7 _ |a 2165-5391
|2 ISSN
024 7 _ |a WOS:000300074600002
|2 WOS
037 _ _ |a FZJ-2015-04385
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Sgobba, Miriam
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Molecular dynamics of HIV1-integrase in complex with 93del - a structural perspective on the mechanism of inhibition.
260 _ _ |a Abingdon, Oxon
|c 2012
|b Taylor & Francis63883
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1435741409_5524
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a HIV1 integrase is an important target for the antiviral therapy. Guanine-rich quadruplex, such as 93del, have been shown to be potent inhibitors of this enzyme and thus representing a new class of antiviral agents. Although X-ray and NMR structures of HIV1 integrase and 93del have been reported, there is no structural information of the complex and the mechanism of inhibition still remains unexplored. A number of computational methods including automated protein-DNA docking and molecular dynamics simulation in explicit solvent were used to model the binding of 93del to HIV1 integrase. Analysis of the dynamic behaviour of the complex using principal components analysis and elastic network modelling techniques allow us to understand how the binding of 93del aptamer and its interactions with key residues affect the intrinsic motions of the catalytic loops by stabilising them in catalytically inactive conformations. Such insights into the structural mechanism of inhibition can aid in improving the design of anti-HIV aptamers.
536 _ _ |a 452 - Structural Biology (POF2-452)
|0 G:(DE-HGF)POF2-452
|c POF2-452
|f POF II
|x 0
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de, PubMed,
650 _ 7 |a Aptamers, Nucleotide
|2 NLM Chemicals
650 _ 7 |a HIV Integrase Inhibitors
|2 NLM Chemicals
650 _ 7 |a p31 integrase protein, Human immunodeficiency virus 1
|2 NLM Chemicals
650 _ 7 |a HIV Integrase
|0 EC 2.7.7.-
|2 NLM Chemicals
700 1 _ |a Olubiyi, Olujide
|0 P:(DE-Juel1)138971
|b 1
700 1 _ |a Ke, Song
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Haider, Shozeb
|0 P:(DE-HGF)0
|b 3
|e Corresponding Author
773 _ _ |a 10.1080/07391102.2012.10507418
|g Vol. 29, no. 5, p. 863 - 877
|0 PERI:(DE-600)2517146-X
|n 5
|p 863 - 877
|t Caryologia
|v 29
|y 2012
|x 1538-0254
909 C O |o oai:juser.fz-juelich.de:202096
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)138971
913 2 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-551
|2 G:(DE-HGF)POF3-500
|v Functional Macromolecules and Complexes
|x 0
913 1 _ |a DE-HGF
|b Schlüsseltechnologien
|1 G:(DE-HGF)POF2-450
|0 G:(DE-HGF)POF2-452
|2 G:(DE-HGF)POF2-400
|v Structural Biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l BioSoft
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21